213 related articles for article (PubMed ID: 18797411)
1. Tumor necrosis factor alpha-308 and -238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-alpha.
Oregón-Romero E; Vázquez-Del Mercado M; Ruiz-Quezada SL; Navarro-Hernández RE; Rangel-Villalobos H; Martínez-Bonilla G; Bernard-Medina AG; Armendáriz-Borunda J; García-Bañuelos J; Muñoz-Valle JF
J Investig Med; 2008 Oct; 56(7):937-43. PubMed ID: 18797411
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
3. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-α.
Jahid M; Rehan-Ul-Haq ; Jha PK; Chawla D; Avasthi R; Ahmed RS
Clin Rheumatol; 2017 Oct; 36(10):2209-2216. PubMed ID: 28748515
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis.
Tolusso B; Sacco S; Gremese E; La Torre G; Tomietto P; Ferraccioli GF
Hum Immunol; 2004 Dec; 65(12):1420-6. PubMed ID: 15603867
[TBL] [Abstract][Full Text] [Related]
6. High expression of TNF alpha is associated with -308 and -238 TNF alpha polymorphisms in knee osteoarthritis.
Muñoz-Valle JF; Oregón-Romero E; Rangel-Villalobos H; Martínez-Bonilla GE; Castañeda-Saucedo E; Salgado-Goytia L; Leyva-Vázquez MA; Illades-Aguiar B; Alarcón-Romero Ldel C; Espinoza-Rojo M; Parra-Rojas I
Clin Exp Med; 2014 Feb; 14(1):61-7. PubMed ID: 23108479
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
Lagha A; Zidi S; Stayoussef M; Gazouani E; Kochkar R; Kochbati S; Almawi WY; Yacoubi-Loueslati B
Pathol Biol (Paris); 2015 Sep; 63(4-5):179-84. PubMed ID: 26003199
[TBL] [Abstract][Full Text] [Related]
8. The association between TNFα gene polymorphisms and susceptibility to rheumatoid arthritis in an ethnic Kashmiri population: relationship with disease activity and severity markers.
Shafia S; Sofi FA; Dilafroze ; Rasool R; Javeed S; Shah ZA
Int J Rheum Dis; 2016 Apr; 19(4):362-9. PubMed ID: 24382334
[TBL] [Abstract][Full Text] [Related]
9. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.
Seitz M; Wirthmüller U; Möller B; Villiger PM
Rheumatology (Oxford); 2007 Jan; 46(1):93-6. PubMed ID: 16720636
[TBL] [Abstract][Full Text] [Related]
10. Association of
Gautam S; Kumar U; Kumar M; Kanga U; Dada R
Immunol Invest; 2020 Feb; 49(1-2):88-105. PubMed ID: 31549885
[No Abstract] [Full Text] [Related]
11. Lack of association of tumor necrosis factor alpha gene polymorphism in patients with rheumatoid arthritis in central Taiwan.
Lo SF; Huang CM; Wu MC; Wu JY; Tsai FJ
Rheumatol Int; 2003 Jul; 23(4):151-3. PubMed ID: 12750939
[TBL] [Abstract][Full Text] [Related]
12. sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity.
Navarro-Hernández RE; Oregón-Romero E; Rangel-Villalobos H; Vázquez-Del Mercado M; Ruiz-Quezada SL; Maldonado-González M; Torres-Vitela R; Muñoz-Valle JF
J Rheumatol; 2006 Oct; 33(10):1968-72. PubMed ID: 17014013
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Florczak M; Ostanek L; Brzosko M; Brzosko I; Szklarz BG
Scand J Rheumatol; 2005; 34(1):22-6. PubMed ID: 15903021
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population.
Nemec P; Pavkova-Goldbergova M; Stouracova M; Vasku A; Soucek M; Gatterova J
Clin Rheumatol; 2008 Jan; 27(1):59-65. PubMed ID: 17562093
[TBL] [Abstract][Full Text] [Related]
15. The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population.
Reyes-Castillo Z; Pereira-Suárez AL; Palafox-Sanchez CA; Rangel-Villalobos H; Estrada-Chávez C; Oregón-Romero E; Angel-Chávez LI; Muñoz-Barrios S; Bueno-Topete MR; Muñoz-Valle JF
Gene; 2013 Aug; 525(1):130-5. PubMed ID: 23660301
[TBL] [Abstract][Full Text] [Related]
16. The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.
Torres-Carrillo NM; Torres-Carrillo N; Vázquez-Del Mercado M; Delgado-Rizo V; Oregón-Romero E; Parra-Rojas I; Muñoz-Valle JF
Rheumatol Int; 2008 Feb; 28(4):355-60. PubMed ID: 17899094
[TBL] [Abstract][Full Text] [Related]
17. F11R mRNA expression and promoter polymorphisms in patients with rheumatoid arthritis.
Fang TJ; Lin CH; Lin YZ; Li RN; Ou TT; Wu CC; Tsai WC; Yen JH
Int J Rheum Dis; 2016 Feb; 19(2):127-33. PubMed ID: 26230081
[TBL] [Abstract][Full Text] [Related]
18. Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms.
Navarro-Hernández RE; Oregon-Romero E; Vázquez-Del Mercado M; Rangel-Villalobos H; Palafox-Sánchez CA; Muñoz-Valle JF
Dis Markers; 2009; 26(3):119-26. PubMed ID: 19597294
[TBL] [Abstract][Full Text] [Related]
19. Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response.
Pachot A; Arnaud B; Marrote H; Cazalis MA; Diasparra J; Gouraud A; Mougin B; Miossec P
J Rheumatol; 2007 Nov; 34(11):2158-61. PubMed ID: 17896807
[TBL] [Abstract][Full Text] [Related]
20. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
Sugihara M; Tsutsumi A; Suzuki E; Wakamatsu E; Suzuki T; Ogishima H; Hayashi T; Chino Y; Ishii W; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
Arthritis Rheum; 2007 Jul; 56(7):2160-9. PubMed ID: 17599736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
